Relmada Therapeutics
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2222 Ponce de Leon Blvd Fl 3, Coral Gabl...Phone Number
(786) 629-1376Website
www.relmada.comRevenue
-Stock Symbol
RLMDIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
2
1
1
About Relmada Therapeutics
Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Relmada's experienced and dedicated team is committed to making a difference in the lives of patients and their families. In addition, Relmada is advancing a clinical-stage program in neurodegenerative diseases based on psilocybin and select derivative molecules.Explore more
Relmada Therapeutics Org Chart
MT
Corporate Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Relmada Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Relmada Therapeutics
Check if Relmada Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Relmada Therapeutics had a recent Job posting/layoffs
Relmada Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Relmada Therapeutics has new funding data
Product Launch: Get notified when Relmada Therapeutics launches new products
Check out if Relmada Therapeutics is spiking on competitors!
Earning: See what the market has to say on Relmada Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Relmada Therapeutics
Compare insights from companies similar to Relmada Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Relmada Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Relmada Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Relmada Therapeutics.
Relmada Therapeutics financials insights
Gather financial insights about Relmada Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Debt
$6.9M
2026
Stock/Share Issuance
$160M
Relmada Therapeutics Tech Stack
A closer look at the technologies used by Relmada Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Earnings
closed Q2 2026 with cash equivalents and short-term investments of $217.7 million, compared to $93 million as of December 31, 2025, with current cash resources expected to fund company operations through 2029, including completion of the Phase III RESCUE program for NDV-01.
Earnings, Financial Planning, Business Finance, Finance, Financial Operations, Financial Strategy
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Relmada Therapeutics News & Media
Relmada Therapeutics, Inc. (RLMD) Q2 2026 Earnings Call Transcript
Relmada Therapeutics, Inc. (RLMD) Q2 2026 Earnings Call August 6, 2026 4:30 PM EDTCompany ParticipantsJoyce LonerganSergio Traversa - CEO &...Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
CORAL GABLES, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today reported financial results for the second quarter ended June 30, 2026, and provided a business update.Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
CORAL GABLES, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced the appointment of Bipin Dalmia, PhD, MBA, as Chief Business Officer. Bipin will lead Relmada's corporate strategy, commercial planning, and business development activities, reporting directly to Chief Executive Officer Sergio Traversa.Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
CORAL GABLES, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced plans to host a conference call and webcast on Thursday, August 6, 2026 at 4:30 PM ET to discuss financial results for the second quarter ended June 30, 2026, and recent business progress.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Relmada Therapeutics
Sign Up For FreeTo access detailed company insights
Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Relmada's experienced and dedicated team is committed to making a difference in the lives of patients and their families. In addition, Relmada is advancing a clinical-stage program in n... Read More
